Download PDF
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Efficacy and safety of using ELEXACAFTOR/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil
Guilherme da Silva Martins; Carolina Rambo; Gabriela Spessatto; Maitê Milagres Saab; Bruno Hernandes David João; Aline Didoni Fajardo; Juliana Gonçalves Primon; Thalita Gonçalves Picciani; Roberta Corrêa da Cunha; Herberto José Chong-Neto; Carlos Roberto Lebarbenchon Massignan; Luiz Vicente Ribeiro Ferreira da Silva Filho; Carlos Antônio Riedi; Nelson Augusto Rosário Filho; Débora Carla Chong-Silva;
10.1016/j.jped.2025.05.007
Predictive factors for premature birth and respiratory exacerbation in pregnancies of women with cystic fibrosis
Vanessa de Souza Vieira; Taiane dos Santos Feiten; Renata Salatti Ferrari; Paulo de Tarso Roth Dalcin; Bruna Ziegler;
J Pediatr (Rio J). 2022;98:33-8
Failure of immunological competence: when to suspect?
Fernanda Pinto-Mariz;
J Pediatr (Rio J). 2021;97 Supl 1:S34-8